| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |